When does this change take effect?

This change is effective Mar 5, 2025.

Medicare AdvantageCoverageMedium impact

MA09.008a, Low Osmolar Contrast Agents

Q: Who is affected by this change?

This affects Independence Blue Cross Radiology, Cardiology, Vascular Surgery, Neurology, Urology, Diagnostic Imaging providers on Medicare Advantage plans.

Independence Blue Cross·Radiology, Cardiology, Vascular Surgery +3 more·Medical Policy

Effective date

Mar 5, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

Medicare Advantage policy MA09.008a regarding Low Osmolar Contrast Agents has been reissued with an effective date of March 5, 2025. This is a policy update that may affect billing and coverage requirements for procedures using low osmolar contrast agents.

Action Required

Action needed

By March 5, 2025: Billing team must review the complete policy MA09.008a for Low Osmolar Contrast Agents at the source URL to understand specific coverage changes, billing requirements, and documentation needs. Update billing procedures and staff training accordingly for all procedures involving low osmolar contrast agents.

Related policy hubs

Independence Blue Cross policies Radiology Cardiology Vascular Surgery Neurology Urology Diagnostic Imaging